Impact of obesity on hypertension-induced cardiac remodeling: role of oxidative stress and its modulation by gemfibrozil treatment in rats

被引:18
作者
Singh, Randhir [2 ]
Singh, Amrit Pal [1 ,2 ]
Singh, Manjeet [2 ]
Krishan, Pawan [2 ]
机构
[1] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar 143005, Punjab, India
[2] Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Patiala 147002, Punjab, India
关键词
Cardiac hypertrophy; Cardiac fibrosis; Obesity; Oxidative stress; Gemfibrozil; Free radicals; ACTIVATED RECEPTOR-ALPHA; CARDIOVASCULAR-DISEASE; SIGNALING PATHWAYS; ANGIOTENSIN-II; RISK-FACTOR; HYPERTROPHY; HEART; DYSFUNCTION; MICE; FENOFIBRATE;
D O I
10.1016/j.freeradbiomed.2010.11.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study investigated the possible synergistic role of obesity in hypertension-induced cardiac remodeling and its modulation by gemfibrozil treatment in rats. Male Wistar rats were fed a high-fat diet (HFD) for 90 days. Normal rats were subjected to hypertension by partial abdominal aortic constriction (PAAC) for 28 days. In the HFD + PAAC control group, rats on HFD were subjected to PAAC on the 62nd day and were sacrificed on the 90th day. HFD and PAAC individually resulted in significant cardiac hypertrophy and fibrosis along with increased oxidative stress and mean arterial blood pressure (MABP) in rats as evidenced by various morphological, biochemical, and histological parameters. Moreover, the HFD + PAAC control group showed marked cardiac remodeling compared to rats subjected to HFD or PAAC alone. The HFD + gemfibrozil and HFD + PAAC + gemfibrozil groups showed significant reduction in cardiac remodeling along with reduction in oxidative stress and MABP. Hence, it may be concluded that oxidative stress plays a key role in obesity-mediated synergistic effects on induction and progression of PAAC-induced cardiac remodeling, and its deleterious effects could be reversed by gemfibrozil treatment in rats through its antioxidant activity. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:363 / 370
页数:8
相关论文
共 40 条
[1]   Molecular targets and regulators of cardiac hypertrophy [J].
Agrawal, Rohini ;
Agrawal, Neeraj ;
Koyani, Chintan N. ;
Singh, Randhir .
PHARMACOLOGICAL RESEARCH, 2010, 61 (04) :269-280
[2]   Reactive oxygen species in mechanical stress-induced cardiac hypertrophy [J].
Aikawa, R ;
Nagai, T ;
Tanaka, M ;
Zou, YZ ;
Ishihara, T ;
Takano, H ;
Hasegawa, H ;
Akazawa, H ;
Mizukami, M ;
Nagai, R ;
Komuro, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (04) :901-907
[3]  
Balakumar Pitchai, 2007, Journal of Pharmacological and Toxicological Methods, V56, P1, DOI 10.1016/j.vascn.2007.01.003
[4]   PPAR ligands: Are they potential agents for cardiovascular disorders? [J].
Balakumar, Pitchai ;
Rose, Madhankumar ;
Singh, Manjeet .
PHARMACOLOGY, 2007, 80 (01) :1-10
[5]   Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth [J].
Barger, PM ;
Brandt, JM ;
Leone, TC ;
Weinheimer, CJ ;
Kelly, DP .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1723-1730
[6]  
BEUTLER E, 1963, J LAB CLIN MED, V61, P882
[7]   Medical consequences of obesity [J].
Bray, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2583-2589
[8]   Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation [J].
Calkin, AC ;
Cooper, ME ;
Jandeleit-Dahm, KA ;
Allen, TJ .
DIABETOLOGIA, 2006, 49 (04) :766-774
[9]   Cardiac lipid accumulation associated with diastolic dysfunction in obese mice [J].
Christoffersen, C ;
Bollano, E ;
Lindegaard, MLS ;
Bartels, ED ;
Goetze, JP ;
Andersen, CB ;
Nielsen, LB .
ENDOCRINOLOGY, 2003, 144 (08) :3483-3490
[10]   Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide [J].
Di Wang, H ;
Pagano, PJ ;
Du, Y ;
Cayatte, AJ ;
Quinn, MT ;
Brecher, P ;
Cohen, RA .
CIRCULATION RESEARCH, 1998, 82 (07) :810-818